| Serial Number | 98207152 |
| Word Mark | EVIDA |
| Filing Date | Monday, October 2, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Wednesday, December 17, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 19, 2024 |
| Goods and Services | Medical services, namely, medical diagnostic, evaluation and screening services; healthcare services, namely, disease management services; medical services, namely, therapeutic drug monitoring and precision-guided dosing services; medical services, namely, providing medical information to health care providers, managed care providers and patients via global computer networks; providing health information in the field of inflammatory and immune-mediated diseases, ulcerative colitis, Crohn's disease, rheumatological diseases, rheumatoid arthritis, psoriatic arthritis, system lupus erythematosus, dermatological diseases, psoriasis, hidradenitis suppurativa, neurological disease, Alzheimer's disease, and migraines; providing medical information relating to medical diagnostic testing; medical consultation; providing a website featuring health care information about services for the diagnosis, prevention, and treatment of inflammatory and immune-mediated diseases |
| Goods and Services | Medical research laboratory services featuring testing for medical research purposes; medical research services; providing medical and scientific research information in the field of pharmaceuticals, pharmaceutical discovery and clinical trials to medical and research professionals; providing a website featuring medical research information about medical diagnostics; consulting services in the fields of biotechnology, pharmaceutical discovery, pharmaceutical research and development, medical research laboratory testing, medical diagnostics, proteomics, metabolomics, glycomics, genomics and genetics; pharmaceutical and medical research services; providing medical and scientific research information in the fields of pharmaceuticals, proteomics, metabolomics, glycomics, genomics and genetics |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 12, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 12, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Prometheus Laboratories, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Prometheus Laboratories, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Thursday, October 5, 2023 | NEW APPLICATION ENTERED |
| Thursday, October 12, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 22, 2024 | ASSIGNED TO EXAMINER |
| Monday, August 19, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, August 19, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, August 19, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, August 19, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, August 19, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, August 19, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, August 19, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, August 19, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, August 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 1, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 1, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 19, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 19, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 31, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 14, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 14, 2025 | SOU EXTENSION 1 FILED |
| Wednesday, January 15, 2025 | SOU EXTENSION 1 GRANTED |
| Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 16, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 16, 2025 | SOU EXTENSION 2 FILED |
| Wednesday, December 17, 2025 | SOU EXTENSION 2 GRANTED |
| Wednesday, December 17, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |